跳至主要内容
临床试验/CTRI/2017/04/008424
CTRI/2017/04/008424已完成3 期

A open label, randomized, comparative study on efficacy , safety and reduction of diabetic complications, with regimens of metformin, glimeperide, &vildagliptinvs metformin, Glimeperide, &dapagliflozin in type â?? 2 diabetic patients.

Siddhartha Medical College0 个研究点目标入组 435 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
435

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Males and Females of age between 30-60 years
  • Type â?? 2 diabetics already on treatment but with uncontrolled blood sugars.
  • Type â?? 2 diabetics with hypertension.
  • Type â?? 2 diabetics with obesity.

排除标准

  • Males and Females of age above 60 years .
  • Newly diagnosed cases of Type â?? 2. Type â?? 2 diabetics with other endocrinological disorders like hypo or hyperthyroidism, cushingâ??s syndrome and acromegaly, Type â?? 2 diabetics with pancreatic disorders like pancreatitis.
  • , Type â?? 2 Diabetics with acute complications.
  • Type â?? 2 Diabetics on drugs like thiazide diuretics, corticosteroids, oral contraceptive pills, protease inhibitors.
  • Other specific types of diabetes like MODY.
  • Type â?? 2 Diabetics with severe renal failure, heart failure, and hepatic failure.
  • Pregnant & lactating women.

研究者

发起方
Siddhartha Medical College

相似试验